S exually transmitted diseases (STDs) are not rare during pregnancy; however, they are usually asymptomatic and may be unrecognized. STDs in pregnancy can cause serious complications to both pregnant women and fetuses. Screening tests are recommended, because the treatment of these diseases can be curative in most cases, or at least effective in reducing complications. In this point of view, the Centers for Disease Control and Prevention recommends screening of all pregnant women for several STDs including human immunodeficiency virus (HIV) infection, hepatitis B, and syphilis, and screening selectively in high risk women for gonorrhea and hepatitis C. To reduce vertical transmissions, highly active antiretroviral therapy and timed Cesarean delivery is recommended in HIV-infected pregnant women. Penicillin is still a drug of choice for syphilis in pregnancy. In women who have active genital herpetic lesions at the time of labor, Cesarean delivery is indicated to protect neonates from perinatal transmissions. However, in women who have genital warts with human papilloma virus infection, Cesarean delivery is not recommended to prevent neonatal laryngeal papillomatosis. In women infected with gonorrhea, Chlamydia or Trichomonas, tests for HIV infection are recommended because of high prevalence of concomitant infections.
- Women with a history of injection drug use, repeated exposure to blood products, or blood transfusion or organ transplant before 1992.
------- 
Time of Administration Zidovudine Regimen
Antepartum 100 mg orally five times daily, initiated at 14 to 34 weeks and continued throughout the pregnancy. a
Intrapartum
During labor, intravenous zidovudine in a 1-hour initial dose of 2 mg/kg, followed by a continuous infusion of 1 mg/kg/hr until delivery. b
Neonate
Begin at 8 to 12 hours after birth, and give syrup at 2 mg/kg every 6 hours for 6 weeks. c a Acceptable alternative regimens include 200 mg three times daily or 300 mg twice daily. b For elective cesarean delivery, intravenous zidovudine is begun at least 3 hours prior to surgery. For premature rupture of membranes or labor with a planned operative delivery, the loading dose may be given during 30 minutes prior to surgery. c Intravenous dosage for infants who cannot tolerate oral intake is 1.5 mg/kg intravenously every 6 hours. From U.S. Public Health Service, 2003. (21) 
